Mood swings have become the norm when it comes to the potential of the African continent. Pre 1990’s was described as the dark days of Africa. Post-1990 into the early decades of this 21st century saw an uproar and cheers all over the world for the continent as the next big thing to happen. After…
Accountants and credit controllers are on the frontline of ensuring an organisation’s financial health. This involves a number of key processes, including cost accounting. It is vital in today’s economy for accountants to be familiar with both cost reduction and cost control – two similar but significantly different ways to monitor and modify organisational costs.…
The meteoric rise of fintech has left many traditional financial institutions lagging behind in terms of technology – and many banks have chosen to see this as a threat. In a 2015 survey by PwC, 83 percent of financial services professionals indicated that they were concerned about losing business to new fintech startups. The fintech…
In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…
Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to source solutions and expertise that could meet the needs of the Saudi market. Healthcare is…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…
The concept of organisational cost reduction has been at the top of corporate agendas ever since the global financial crisis of 2008-2009. In the immediate aftermath of the global recession, organisational cost reduction emerged as not only a necessity, but also a field that provided ample scope for innovation. For a long time, the question…
With a recent cost survey by Deloitte showing that 88 percent of companies will be pursuing cost-reduction measures over the next 24 months, effective cost strategies have never been in greater demand. As part of Naseba’s ongoing effort to meet this demand, we’ve researched and summarised 10 key strategies to help your organisation cut costs…
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…